Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TANDPLEJERKLINIKKEN FILOSOFGANGEN ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   3.7% 2.2% 2.5% 2.8% 3.6% 2.3% 14.3% 13.9%   Credit score (0-100)   53 67 62 57 52 63 15 16   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   4,391 3,765 3,415 3,790 3,852 3,138 3,138 3,138   Gross profit   3,480 3,005 2,719 2,951 3,005 2,348 0.0 0.0   EBITDA   1,022 664 444 472 722 345 0.0 0.0   EBIT   841 514 307 370 607 318 0.0 0.0   Pre-tax profit (PTP)   843.1 514.2 304.8 365.1 603.5 318.9 0.0 0.0   Net earnings   656.4 400.2 236.0 273.2 477.6 246.2 0.0 0.0   Pre-tax profit without non-rec. items   843 514 305 365 603 319 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   594 500 401 371 374 518 0.0 0.0   Shareholders equity total   969 769 705 678 956 902 472 472   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,459 1,280 1,136 987 1,256 1,190 472 472   Net Debt   -650 -595 -547 -215 -572 -529 -452 -452     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   4,391 3,765 3,415 3,790 3,852 3,138 3,138 3,138   Net sales growth   -4.1% -14.3% -9.3% 11.0% 1.6% -18.5% 0.0% 0.0%   Gross profit   3,480 3,005 2,719 2,951 3,005 2,348 0.0 0.0   Gross profit growth   -2.8% -13.6% -9.5% 8.5% 1.8% -21.9% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,459 1,280 1,136 987 1,256 1,190 472 472   Balance sheet change%   -6.1% -12.3% -11.2% -13.1% 27.2% -5.3% -60.3% 0.0%   Added value   1,022.5 663.5 443.7 471.6 708.0 344.9 0.0 0.0   Added value %   23.3% 17.6% 13.0% 12.4% 18.4% 11.0% 0.0% 0.0%   Investments   110 -243 -236 -132 -113 117 -518 0   Net sales trend   -1.0 -2.0 -3.0 1.0 2.0 -1.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   23.3% 17.6% 13.0% 12.4% 18.8% 11.0% 0.0% 0.0%   EBIT %   19.2% 13.6% 9.0% 9.8% 15.7% 10.1% 0.0% 0.0%   EBIT to gross profit (%)   24.2% 17.1% 11.3% 12.5% 20.2% 13.6% 0.0% 0.0%   Net Earnings %   14.9% 10.6% 6.9% 7.2% 12.4% 7.8% 0.0% 0.0%   Profit before depreciation and extraordinary items %   19.1% 14.6% 10.9% 9.9% 15.4% 8.7% 0.0% 0.0%   Pre tax profit less extraordinaries %   19.2% 13.7% 8.9% 9.6% 15.7% 10.2% 0.0% 0.0%   ROA %   56.0% 37.5% 25.4% 34.9% 54.1% 26.1% 0.0% 0.0%   ROI %   83.5% 58.4% 41.2% 52.3% 72.6% 33.4% 0.0% 0.0%   ROE %   66.2% 46.0% 32.0% 39.5% 58.4% 26.5% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   66.4% 60.1% 62.1% 68.7% 76.1% 75.8% 100.0% 100.0%   Relative indebtedness %   10.8% 13.3% 12.3% 7.5% 7.4% 8.0% 0.0% 0.0%   Relative net indebtedness %   -4.0% -2.5% -3.7% 1.9% -7.5% -8.9% -14.4% -14.4%   Net int. bear. debt to EBITDA, %   -63.6% -89.6% -123.3% -45.5% -79.2% -153.4% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.8 1.5 1.7 2.1 3.0 2.6 0.0 0.0   Current Ratio   1.8 1.5 1.7 2.1 3.0 2.6 0.0 0.0   Cash and cash equivalent   650.5 594.7 547.2 214.7 572.4 528.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   9.0 13.2 13.3 15.4 14.6 7.4 0.0 0.0   Trade creditors turnover (days)   67.3 44.8 73.6 40.8 44.0 46.2 0.0 0.0   Current assets / Net sales %   19.3% 20.2% 20.9% 15.7% 22.4% 20.8% 14.4% 14.4%   Net working capital   370.6 257.6 295.0 311.3 577.3 402.3 0.0 0.0   Net working capital %   8.4% 6.8% 8.6% 8.2% 15.0% 12.8% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0